Mar 10 |
We Think Structure Therapeutics (NASDAQ:GPCR) Can Afford To Drive Business Growth
|
Mar 8 |
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference
|
Mar 8 |
Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights
|
Jan 22 |
Here’s Why Structure Therapeutics (GPCR) Fell in Q4
|
Dec 25 |
Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now
|
Dec 22 |
7 Small-Cap Stocks That Wall Street Loves for Good Reason
|
Dec 19 |
Structure Therapeutics And Its Unstructured Weight Loss Data
|
Dec 18 |
Another Drugmaker Hits Rocks Seeking a Weight-Loss Pill
|
Dec 18 |
Structure Therapeutics stock tanks amid Phase 2 obesity drug data
|
Dec 18 |
New Shakeup Hits Obesity Pills. Structure Rolls Out Disappointing Data.
|